US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Phenylephrine 0.8 mg/10 mL NS

Reason Lack of sterility assurance.

CMC Enterprise Pharmacy D-1230-2019
Class II · Moderate risk Terminated

Heparin Pork 30

Reason Lack of sterility assurance.

CMC Enterprise Pharmacy D-1229-2019
Class II · Moderate risk Terminated

Chlorothiazide 100 mg

Reason Lack of sterility assurance.

CMC Enterprise Pharmacy D-1228-2019
Class II · Moderate risk Terminated

CefTRIAXone 1 GM

Reason Lack of sterility assurance.

CMC Enterprise Pharmacy D-1227-2019
Class II · Moderate risk Terminated

CeFAZolin 3 gm 100 mg/mL

Reason Lack of sterility assurance.

CMC Enterprise Pharmacy D-1226-2019
Class II · Moderate risk Terminated

Labetalol 20 mg/4 mL

Reason Lack of sterility assurance.

CMC Enterprise Pharmacy D-1212-2019
Class II · Moderate risk Terminated

Amoxicillin for Oral Suspension USP

Reason Subpotent Product: assay results for Amoxicillin were below the specification limits.

Teva Pharmaceuticals USA NDC 0093-4150-80 D-1205-2019
Class II · Moderate risk Terminated

Divalproex Sodium Extended-Release Tablets

Reason cGMP deviations: Product was exposed above 50% relative humidity levels during packaging operations.

Dr. Reddy's Laboratories, Inc. NDC 55111-0533-01 D-1133-2019
Class II · Moderate risk Terminated

GlipiZIDE Extended-release Tablets

Reason Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release results were slightly above specification at time zero.

American Health Packaging D-1276-2019